SK Bioscience's COVID-19 vaccine clinical trial phase 3 has been approved, causing a sharp rise in stock prices due to the possibility of becoming the first domestically produced vaccine. As the first domestic vaccine, the government has also promised substantial support, leading to a simultaneous surge in related stocks.
▶ If you join us, you are already a passenger on the successful investment train!
So, what is the situation with related stocks? Since predicting the outlook for pharmaceutical and bio stocks is difficult, those who obtained accurate investment information in advance likely spent yesterday with a smile. On the other hand, most who missed the buying timing were confirmed to be “late investors” who mainly invest alone.
There is a saying, “Nothing in the world is free,” and it is naturally limited to earn profits solely by operating investment funds. It is highly recommended to receive stock recommendations through a free trial, and if satisfied, pay a reasonable membership fee to receive strong support from investment analysis experts equipped with advanced analytical skills.
They will never think the amount you paid as a membership fee is a waste or expensive, but will return it as profit.
Interested stock codes: BioLeaders / SK Chemicals / Daewon Pharmaceutical / Codes Combine / NanoEntek
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
